Explore the efficacy and safety of the treatment of Endostar continuous intravenous injection
pump combined GP（gemcitabine+cisplatin） scheme for first-line advanced non small cell lung
cancer and maintenance treatment.
Phase:
Phase 2
Details
Lead Sponsor:
China Medical University, China
Collaborators:
General Hospital of Shenyang Military Region Liaoning Tumor Hospital & Institute Shengjing Hospital The First Affiliated Hospital of Dalian Medical University The Second Affiliated Hospital of Dalian Medical University
Treatments:
Cisplatin Endostar protein Endostatins Gemcitabine